68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617

68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617

Abstract Background Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer. Treatment with surgery, radioactive iodine (RAI), and TSH suppression is effective in most patients. Five to 15% of patients become RAI refractory and need alternative therapy; however, treatment op...

Full description

Bibliographic Details
Main Authors: Lisa H. de Vries, Lutske Lodewijk, Arthur J. A. T. Braat, Gerard C. Krijger, Gerlof D. Valk, Marnix G. E. H. Lam, Inne H. M. Borel Rinkes, Menno R. Vriens, Bart de Keizer
Format: Article
Language:English
Published: SpringerOpen 2020-03-01
Series:EJNMMI Research
Subjects:
Radioactive iodine-refractory differentiated thyroid carcinoma
Prostate-specific membrane antigen
Theranostic
Gallium
Lutetium
PET/CT
Online Access:http://link.springer.com/article/10.1186/s13550-020-0610-x

Internet

http://link.springer.com/article/10.1186/s13550-020-0610-x

Similar Items